The Mayo Clinic has decided to phase out use of Ambien, the prescription sleeping pill, over concerns that patients on the drug have a higher rate fall rate than those who are not on it.
In a study conducted by the Mayo Clinic in Rochester, MN and published in the Journal of Hospital Medicine (11/19/12), researchers reviewed fall data from more than 16,000 patients who were hospitalized. The study found that patients who were given Ambien while hospitalized experienced falls more than four times greater than those who were not given Ambien. According to the study, the fall rate for patients given Ambien was just over 3 percent compared to a fall rate of 0.7 percent for patients not given Ambien.
What’s interesting about the Mayo Clinic Ambien study as well is that the fall rate associated with the drug was greater than that associated with factors such as age, mental impairment, insomnia or delirium. And, that held true no matter what the Ambien dosage was.
According to a report at HealthDay News, the Mayo Clinic’s chief patient safety officer, Dr. Timothy Morgenthaler stated via news release, “As a result of our study, we are now phasing out [Ambien] and moving toward sleep enhancement techniques that are not based on drugs and which we believe are safer and probably as effective.”
While the Mayo Clinic is clearly backing off of Ambien as a sleep aid for in-patient care, the study did not find a cause and effect relationship between taking Ambien and falling; however, the association found between the two in the study was enough for the Mayo Clinic to begin to phase the drug out of use.